Cargando…
Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD
OBJECTIVE: Approximately 18 million people in the U.S. have coexisting type 2 diabetes and nonalcoholic fatty liver disease (NAFLD). It is not known who among these patients has nonalcoholic steatohepatitis (NASH) with advanced fibrosis. Therefore, we aimed to determine factors that are associated w...
Autores principales: | Bazick, Jessica, Donithan, Michele, Neuschwander-Tetri, Brent A., Kleiner, David, Brunt, Elizabeth M., Wilson, Laura, Doo, Ed, Lavine, Joel, Tonascia, James, Loomba, Rohit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477334/ https://www.ncbi.nlm.nih.gov/pubmed/25887357 http://dx.doi.org/10.2337/dc14-1239 |
Ejemplares similares
-
Imaging biomarkers of NAFLD, NASH, and fibrosis
por: Ajmera, Veeral, et al.
Publicado: (2021) -
Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET‐NASH Study
por: Barritt, A. Sidney, et al.
Publicado: (2021) -
miR-196b-5p-enriched extracellular vesicles from tubular epithelial cells mediated aldosterone-induced renal fibrosis in mice with diabetes
por: Hu, Renzhi, et al.
Publicado: (2020) -
Natural History of NAFLD/NASH
por: Ekstedt, Mattias, et al.
Publicado: (2017) -
The role of the microbiome in NAFLD and NASH
por: Kolodziejczyk, Aleksandra A, et al.
Publicado: (2018)